Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1

Conditions

Stomach Neoplasms 34Ovarian Neoplasms 31Peritoneal Neoplasms 28Fallopian Tube Neoplasms 14Colorectal Neoplasms 14Carcinoma, Ovarian Epithelial 13Appendiceal Neoplasms 7Neoplasm Metastasis 5Pancreatic Neoplasms 4Uterine Neoplasms 3Recurrence 3Pseudomyxoma Peritonei 3Neoplasms 3Carcinoma 3Uterine Cervical Neoplasms 2Sarcoma 2Peritoneal Diseases 2Mesothelioma, Malignant 2Mesothelioma 2Hyperthermic Intraperitoneal Chemotherapy 2Gastrointestinal Neoplasms 2Gastric Adenocarcinoma 2Desmoplastic Small Round Cell Tumor 2Colonic Neoplasms 2Wilms Tumor 1Stomach Diseases 1Stage â…¢ Gastric Cancer 1Stage IV Gastric Cancer With Metastasis 1Rhabdomyosarcoma 1Rectal Neoplasms 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 2Tissue Banks 1Pancreaticoduodenectomy 1Paclitaxel 1Mitomycin 1Gemcitabine 1Food, Formulated 1Filgrastim 1Carboplatin 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Peritoneal Diseases × Hyperthermic Intraperitoneal Chemotherapy × Clear all
NCT02754115 2024-11-21

An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Tata Memorial Centre

Recruiting
400 enrolled
GastrointestinalGynecologic

Ovarian Neoplasms, Peritoneal Diseases, Colorectal Neoplasms

NCT02850874 2022-04-27

HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma

Wake Forest University Health Sciences

Phase 2 Withdrawn
Gastrointestinal

Pancreatic Neoplasms, Peritoneal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡